Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRM3 pseudogene 2 (MRM3P2, also called RNMTL1P2 or RNA methyltransferase like 1 pseudogene 2) is a human pseudogene that is homologous to MRM3, a gene encoding mitochondrial rRNA methyltransferase 3, but does not produce a functional protein[1]. Pseudogenes like MRM3P2 may regulate their parent gene’s expression or other genes at the RNA level by acting as decoys or competing for microRNAs and RNA-binding proteins, influencing mRNA stability and translation[2][4][6]. However, there is no current evidence that MRM3P2 serves as a therapeutic target, nor are there drugs, biomarkers, or safety issues associated with this non-coding genomic element.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRM3 pseudogene 2 (MRM3P2).